DNA binding, molecular docking and apoptotic inducing activity of nickel(ii), copper(ii) and zinc(ii) complexes of pyridine-based tetrazolo[1,5-a]pyrimidine ligands
- 24 October 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (105) , 60816-60830
Abstract
Six mononuclear copper(II), nickel(II) and zinc(II) complexes, [ML1Cl2] (1–3) and [M(L2)2Cl2] (4–6), of two biologically active tetrazolo[1,5-a]pyrimidine core ligands, ethyl 5-methyl-7-pyridine-2-yl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate (L1) and ethyl-5-methyl-7-pyridine-4-yl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate (L2), have been synthesized and characterized. The molecular structure of the ligands (L1&2) and complex 6 were determined by single crystal X-ray diffraction. The X-ray crystal structure of 6 confirms that it has a distorted tetrahedral structure with a ZnN2Cl2 coordination environment. All of the complexes exhibit an unusually strong luminescence at room temperature. Electroparamagnetic resonance spectra of copper(II) complexes (2 and 5) show four lines, characteristic of square planar geometry, with nuclear hyperfine spin 3/2. DNA binding studies of complexes with calf-thymus DNA suggest that complexes 2 and 5 bind in the grooves of the DNA. These results were further supported by molecular docking studies. In vitro cytotoxic activities of the ligands (L1&2) and complexes (1–6) against human cancer cell lines such as lung (A549), cervical (HeLa), colon (HCT-15) and a non-cancer human embryonic kidney cell line revealed that the complexes selectively inhibit the growth of cancer cells and are inactive against non-cancer cell lines, whereas the ligands were found to be inactive with both cancer and non-cancer cell lines. The IC50 values of the complexes revealed that the copper(II) complexes (2 and 5) exhibit high cytotoxic activity against colon (HCT-15) cells when compared to the standard drug cisplatin. Furthermore, the live cell and fluorescent imaging of cancer cells show that complexes 2 and 5 induce cell death through apoptosis.Keywords
This publication has 51 references indexed in Scilit:
- Regioselective one-pot synthesis and anti-proliferative and apoptotic effects of some novel tetrazolo[1,5-a]pyrimidine derivativesBioorganic & Medicinal Chemistry, 2010
- Synthesis, crystal structure, theoretical calculation and cytotoxic effect of new Pt(ii), Pd(ii) and Cu(ii) complexes with pyridine-pyrazoles derivativesNew Journal of Chemistry, 2008
- Interaction of rac-[Ru(5,6-dmp)3]2+ with DNA: Enantiospecific DNA Binding and Ligand-Promoted Exciton CouplingInorganic Chemistry, 2005
- Isolation and Crystallographic Characterization of a Solid Precipitate/Intermediate in the Preparation of 5-Substituted 1H-Tetrazoles from Nitrile in WaterInorganic Chemistry, 2003
- Interaction of Some Non‐Platinum Metal Anticancer Complexes WithNucleotides and DNA and The Two‐Pole Complementary Principle (TPCP)Arising TherefromMetal-Based Drugs, 1997
- Evolutionary conservation of a genetic pathway of programmed cell deathJournal of Cellular Biochemistry, 1996
- Infrared spectroscopic study of copper(II) complexes with N-substituted tetrazolesSpectrochimica Acta Part A: Molecular Spectroscopy, 1987
- A procedure for the isolation of deoxyribonucleic acid from micro-organismsJournal of Molecular Biology, 1961
- An Improved Synthesis of 5-Substituted TetrazolesJournal of the American Chemical Society, 1958
- A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic AcidJournal of the American Chemical Society, 1954